Plné znění - 278/2014 Sb.

Sdělení o antigenním složení očkovacích látek pro pravidelná, zvláštní a mimořádná očkování pro rok 2015

278/2014 Sb.

Sdělení Ministerstva zdravotnictví

INFORMACE

278

SDĚLENÍ

Ministerstva xxxxxxxxxxxxx

xx dne 20. listopadu 2014

x xxxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx pro pravidelná, xxxxxxxx x xxxxxxxxx xxxxxxxx xxx xxx 2015

Xxxxxxxxxxxx xxxxxxxxxxxxx podle §80 xxxx. 1 xxxx. x) xxxxxx x. 258/2000 Sb., x ochraně xxxxxxxxx xxxxxx a x xxxxx xxxxxxxxx xxxxxxxxxxxxx xxxxxx, ve xxxxx xxxxxxxxxx xxxxxxxx, stanoví xx xxxxxxx xxxxxxxxxx Xxxxxxx imunizační komise xxxxxxxxx xxxxxxx očkovacích xxxxx xxx xxxxxxxxxx, xxxxxxxx x xxxxxxxxx xxxxxxxx pro xxx 2015:

1. Antiqenní xxxxxxx xxxxxxxxxx látek xxx xxxxxxxxxx xxxxxxxx

1x) xxxxxxxxxxx xxxxxxxx látka xxxxx xxxxxxx, xxxxxxxx kašli (xxxxxxxxxx forma), tetanu, xxxxxx přenosné xxxxx (xxxxxxxxxxxx xxxxx), xxxxxx xxxxxxxxxx X, xxxxxxx xxxxxxxxx Xxxxxxxxxxx influenzae xxx x (XXxXXxxXXXXXX):

Xxxxxxxxx xxxxxxxxxx

Xxxxxxxxx haemagglutinum xxxxxxxxxxxx

Xxxxxxxxx xxxxxxxxx xxxxxxxx xxxxxxxxx

Xxxxxxxxxxx xxxxxxxxxx

Xxxxxx xxxxxxxxxx xxx.

Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X xxxxxxxxxxxxxx

Xxxxx xxxxxxxxxxxxxxx inactivatum xxxxx 1

Xxxxx poliomyelitidis xxxxxxxxxxx xxxxx 2

Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx typus 3

Xxxxxxxxxx Xxx: Xxxxxxxxxxxxxxxxxxx xxxxxxxx Xxxxxxxxxxx xxxxxxxxxx x, Tetani xxxxxxxxxx

XXXX

1xx) xxxxxxxxxxx xxxxxxxx xxxxx xxxxx xxxxxxx, dávivému xxxxx (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx xxxxxxxx xxxxx (inaktivovaná xxxxx), xxxxxx xxxxxxxxxx X, xxxxxxx vyvolaným Xxxxxxxxxxx xxxxxxxxxx typ x ( DTaPHibVHBIPV)

Diphtheriae xxxxxxxxxx

Xxxxxx xxxxxxxxxx

Xxxxxxxx Xxxxxxxxxx xxxxxxxxx

Xxxxxxxxx xxxxxxxxxx

Xxxxxxxxxxxxxx filamentosum

Virus Poliomyelitidis (xxxxxxxxxxxx)

xxxxx 1 (Xxxxxxx)

xxxxx 2 (XXX-1)

xxxxx 3 (Xxxxxxx)

Xxxxxxxxx xxxxxxxxx xxxxxxxxxx X

Xxxxxxxxxxx influenzae xxxx x polysaccharidum

(Polyribosylribitoli xxxxxxxx)

xxxxxxxxx xxx xxxxxx anatoxinum

1b) xxxxxxxx xxxxx proti xxxxxxx, xxxxxxxx kašli (xxxxxxxxxx xxxxx), tetanu (XXxX):

Xxxxxxxxxxx xxxxxxxxxx&xxxx;≥ 30 xxxxxxxxxxxxx xxxxxxxx

Xxxxxx xxxxxxxxxx&xxxx;≥ 40 xxxxxxxxxxxxx xxxxxxxx

Xxxxxxxxx xxxxxxxxxx (XX) 25 xxxxxxxxxx

Xxxxxxxxx xxxxxxxxxxxxxxx filamentosum (XXX) 25 xxxxxxxxxx

Xxxxxxxxxxx (69xX) 8 xxxxxxxxxx

1x) xxxxxxxx látka xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx forma), xxxxxx, xxxxxxx xxxxxxxxx Xxxxxxxxx xxxxxxxxxx b (DTaPHib):

Diphtheriae xxxxxxxxxx ........................................... xxx. 30 mezinárodních xxxxxxxx

Xxxxxx xxxxxxxxxx .................................................... xxx. 40 xxxxxxxxxxxxx jednotek

Pertussis xxxxxxxxxx (PT) ...................................... 25 xxxxxxxxxx

Xxxxxxxxx haemaglutininum xxxxxxxxxxxx (XXX) .... 25 xxxxxxxxxx

Xxxxxxxxxxx (69xX) ................................................... 8 xxxxxxxxxx

Xxxxxxxxxxx xxxxxxxxxx X ....................................... 10 xxxxxxxxxx

xxx xxxxxxxxx xxxxxxxx ............................................ 20-40 xxxxxxxxxx

1x) očkovací xxxxx xxxxx nákazám vyvolaným Xxxxxxxxxxx xxxxxxxxxx typ x:

1 xxxxx xxxxxxxxxxxxx xxxxxxx xxxxxxxx: Xxxxxxxxxxxxxxx Xxx purificatum (10 xxxxxxxxxx) xxx Anatoxino xxxxxxxx (xxxxxxxxx 25 xxxxxxxxxx).

1x) xxxxxxxx xxxxx xxxxx xxxxxx:

Xxxxxx anatoxinum ................................................... xxx. 40 xxxxxxxxxxxxx xxxxxxxx

1x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx B xx 15 xxx xxxx:

Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X .......................... 10 xxxxxxxxxx

1x) xxxxxxxx xxxxx proti xxxxxx hepatitidě B xx 16 xxx x výše:

Antigenum xxxxxxxxx xxxxxxxxxxx X ........................... 20 xxxxxxxxxx

1x) očkovací xxxxx xxxxx xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxx:

Xxxxxxxxxxx xxxxx xxxxxxxxxx (Xxxxxxx) xxx. 10^3,0 xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx₅₀

Xxxxxxxxxxx virus attenuatum (XXX 4385) xxx. 10^3,7 xxxxxxxx xxxxx xxx xxxxxxxx kulturu₅₀

Rubeolae xxxxx xxxxxxxxxx (Xxxxxx XX 27/3) xxx. 10^3,0 infekční dávka xxx buněčnou xxxxxxx₅₀

1xx) xxxxxxxx xxxxx proti xxxxxx xxxxxxxx obrně x xxxxxxxxxxxx formě:

Virus xxxxxxxxxxxxx xxxxxxxxxxx typus 1 (Xxxxxxx) ........... 40 xxxxxxxxxxx X xxxxxxxx*

Xxxxx xxxxxxxxxxxxx inactivatum xxxxx 2 (XXX-1) ................ 8 xxxxxxxxxxx X jednotek*

Virus poliomyelitis xxxxxxxxxxx xxxxx 3 (Xxxxxxx) ............. 32 xxxxxxxxxxx D jednotek*

* xxxx xxxxxxxx ekvivalentních xxxxxxxx stanovené xxxxxx xxxxxx xxxxxxxxxxxxx metody.

1i) xxxxxxxx xxxxx xxxxx xxxxxxx vyvolaným Streptococcus xxxxxxxxxx v xxxxxxxxxxxxxxx xxxxxxx:

Xxxxxxxxxxxxxxx Streptococci xxxxxxxxxx xxxxx:

1, 2, 3, 4, 5, 6X, 7X, 8, 9X, 9X, 10A, 11 X, 12X, 14, 15X, 17F, 18X, 19X, 19X, 20, 22X, 23X, 33F ...... 25 xxxxxxxxxx x xxxxxxx xxxxxxxx

1x) xxxxxxxx xxxxx xxxxxxxxxxx xxxxx pneumokokovým infekcím:

Pneumococcale xxxxxxxxxxxxxxx xxxxxxxxx 1

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 3

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 4

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 5

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 6X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 6X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 7F

Pneumococcale xxxxxxxxxxxxxxx xxxxxxxxx 9X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 14

Pneumococcale xxxxxxxxxxxxxxx sérotypus 18X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 19X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 19F

Pneumococcale xxxxxxxxxxxxxxx sérotypus 23F

1ka) xxxxxxxx látka xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), tetanu, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx):

Xxxxxxxxxxx xxxxxxxxxx ............................... xx méně xxx 2 mezinárodní xxxxxxxx

Xxxxxx xxxxxxxxxx ........................................ xx xxxx xxx 20 xxxxxxxxxxxxx xxxxxxxx

Xxxxxxxxx xxxxxxxx:

Xxxxxxxxx xxxxxxxxxx................................... 8 xxxxxxxxxx

Xxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxx ... 8 xxxxxxxxxx

Xxxxxxxxx ...................................................... 2,5 xxxxxxxxxx

Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx:

xxxxx 1 (xxxx Xxxxxxx) .............................. 40 X jednotek xxxxxxxx

xxxxx 2 (xxxx XXX-1) ................................... 8 X xxxxxxxx xxxxxxxx

xxxxx 3 (kmen Xxxxxxx) ................................ 32 D xxxxxxxx xxxxxxxx

XXXX

1xx) očkovací xxxxx xxxxx xxxxxxx, xxxxxxxx kašli (acelulární xxxxx), xxxxxx, dětské xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx):

Xxxxxxxxxx xxxxxx ....................................... xxxx nebo xxxxx 2 mezinárodní jednotky (2 Xx)

Xxxxxxxxx xxxxxx ....................................... xxxx nebo xxxxx 20 xxxxxxxxxxxxx xxxxxxxx (5 Xx)

Xxxxxxxxx xxxxxxxx:

Xxxxxxxxx toxoid ................................ 2,5 mikrogramu

Filamentózní hemaglutinin ................. 5 mikrogramů

Fimbrie xxxx 2+3 ................................ 5 mikrogramů

Pertaktin ............................................. 3 xxxxxxxxxx

Xxxxx xxxxxxxxxxxxx xxxx 1 (inaktivovaný) ... 40 xxxxxxxxxxx X jednotek

Virus xxxxxxxxxxxxx xxxx 2 (xxxxxxxxxxxx) ... 8 antigenních X jednotek

Virus poliomyelitis xxxx 3 (xxxxxxxxxxxx) ... 32 xxxxxxxxxxx X xxxxxxxx

1x) xxxxxxxx xxxxx proti xxxxxxxxxxx:

Xxxxxxxxxxxxx xxxxx xxxxxxxxxx (BCG) xxxxxxx Danisuc 1331 ... 0,75 xx&xxxx;≥ 2,0 x 10⁶ ≤ 8,0 x 10⁶ CFU (živých xxxxxxx)

1x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X xxx osoby xxxxxxxx do dialyzačního xxxxxxxx:

Xxxxxxxxx xxxxxxxxx hepatitidis X xxxxxxxxxxxxxx 20 xxxxxxxxxx; xxxxxxxx XX04X xxxxxxxxxx 3-O-deacyl-4-monofosforyl-lipid A (XXX) 50 xxxxxxxxxx x 1 dávce

2. Xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx pro xxxxxxxx xxxxxxxx

2x) očkovací xxxxx xxxxx xxxxxx xxxxxxxxxx X ve formuli xxx xxxxxxx:

Xxxxxxxxx tegiminis xxxxxxxxxxx X 20 xxxxxxxxxx

2x) xxxxxxxx látka xxxxx xxxxxxxxx

Xxxxx xxxxxx xxxxxxxxxxx (kmen Xxxxxx xxxxxx PM/WI 38&xxxx;1503-3X xxxx xxxx xxxxx 2,5 xxxxxxxxxxxxx jednotek x 1 xxxxx (0,5 xx)

2x) xxxxxxxx xxxxx proti xxxxxx xxxxxxxxxx X xx xxxxxxx pro xxxxxxx:

Xxxxxxxxx X xxxxx xxxxxxxxxxx

3. Xxxxxxxxx složení očkovacích xxxxx xxx mimořádná xxxxxxxx

3x) xxxxxxxx látka xxxxx xxxxxx xxxxxxxxxx X ve xxxxxxx xxx xxxxxxx:

Xxxxxxxxx A xxxxx inactivatum

3b) očkovací xxxxx xxxxx xxxxxx xxxxxxxxxx A ve xxxxxxx pro xxxx:

Xxxxx xxxxxxxxx A xxxxxxxxxxx

X xxxx 2015 x xxxxxxx xx plánovanou xxxxxxxxxx vyhlášky č. 537/2006 Sb., x xxxxxxxx xxxxx xxxxxxxxx nemocem, xxxxx xxxxxxxx xxxxxxxxx úpravu xxxxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx pro xxxxxxxxxx xxxxxxxx xxxxxxxxxxxx nového xxxxxxxxxxx xxxxxxx těchto xxxxxxxxxx xxxxx ve Xxxxxx xxxxxx.

Xxxxxxx:

XXXx. Xxxxxxx, XXX, x. x.

Xxxxxxxxx

Xxxxxx xxxxxxx č. 278/2014 Xx. nabyl xxxxxxxxx dnem 13.12.2014.

Xx xxx xxxxxxxx právní xxxxxxx nebyl xxxxx xx doplňován.

Znění xxxxxxxxxxxx xxxxxxxx xxxxx xxxxxx xxxxxxxx xxxxxxxx v xxxxxxxx xxxx xxxxxxxxxxxxx, xxxxx se xxxx xxxxxx xxxxxxxxx xxxxx xxxxx xxxxxxxxx právního xxxxxxxx.